Common gout drug tested to fight Obesity's hidden inflammation
NCT ID NCT05017571
Summary
This study tested whether a low daily dose of colchicine, an anti-inflammatory drug used for gout, could improve how the body processes sugar in people with obesity. Researchers enrolled 152 adults and adolescents who were overweight, had signs of body-wide inflammation, and high insulin levels but not yet diabetes. Participants took either colchicine or a placebo pill daily for 12 weeks to see if it reduced insulin resistance.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.